Cell Source, Inc. (CLCS) — Shareholders' Equity

Annual figures by fiscal year, from SEC filings.

2012: -$147.4K2013: -$697.3K2014: -$3.78M2015: -$5.76M2016: -$6.24M2017: -$4.56M2018: -$4.92M2019: -$5.74M2020: -$7.95M2021: -$9.83M2022: -$12.63M2023: -$15.61M2024: -$18.54M-$18.54M
2012Shareholders' Equity (USD)2024
Fiscal YearShareholders' EquityChange YoY
2024-$18.54M-18.7%
2023-$15.61M-23.6%
2022-$12.63M-28.6%
2021-$9.83M-23.6%
2020-$7.95M-38.4%
2019-$5.74M-16.7%
2018-$4.92M-8.0%
2017-$4.56M+27.0%
2016-$6.24M-8.4%
2015-$5.76M-52.2%
2014-$3.78M-442.6%
2013-$697.3K-373.2%
2012-$147.4K